myLaurel, a healthcare company delivering home-based acute and transitional care, announced it raised additional capital and held an initial closing of $12 million from existing investors. The funding round was led by Deerfield Management and GV, with participation from Emerson Collective, Pinta Partners, Ochsner Health, and management.
Momentum: This funding follows a record-breaking 2024 and more growth in the first quarter of 2025, marked by a 4 times year-over-year increase in new patient volume and revenue. And myLaurel’s signature Acute Care at Home program continues showing strong clinical and financial outcomes for its hospital partners, most notably through its partnership with Ochsner.
Last year, myLaurel and Ochsner Health jointly developed the Acute Care at Home model, which has since outperformed expectations in clinical and operational metrics. And the partnership has become a benchmark for how health systems can modernize care delivery for complex, frail, and elderly patients outside of traditional hospital walls.
Problem being addressed: As the U.S. population continues to age, the demand for scalable and high-quality care outside the traditional hospital is skyrocketing. The country could face a potentially dangerous threshold of hospital bed shortages, primarily driven by an aging population with increasingly complex medical needs. myLaurel’s model directly addresses this challenge by enabling hospitals to deliver high-acuity care in patients’ homes, improving outcomes while reducing the strain on facility throughput and capacity.
How the funding will be used: The new funding will enable the company to further expand with Ochsner and accelerate growth with new health system clients, focusing on scaling Acute Care at Home in both existing and new markets.
KEY QUOTES:
“Our momentum reflects both the urgency of the need and the strength of our care model solution. In partnership with systems like Ochsner, we demonstrate that high-acuity, home-based care can provide an exceptional patient experience, reduce costs, and meaningfully extend hospital capacity. This funding round validates our vision and positions us to serve more patients with greater efficiency and impact.”
Juan Vallarino, CEO of myLaurel
“myLaurel is pioneering a scalable care model that addresses one of the most pressing challenges in healthcare — how to safely and effectively care for complex patients outside the hospital. We believe myLaurel is well-positioned to lead a transformation in acute care and deliver benefits across the continuum of care.”
Moses Adubi, Principal at Deerfield
